Published in
American Association for the Advancement of Science, Science Translational Medicine, 436(10), 2018
DOI: 10.1126/scitranslmed.aao3003
Links
Tools
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
Journal article published in 2018 by
Luis A. Carvajal 
,
Daniela Ben Neriah,
Adrien Senecal ,
Lumie Benard ,
Victor Thiruthuvanathan ,
Tatyana Yatsenko ,
Swathi-Rao Narayanagari ,
Justin C. Wheat ,
Tihomira I. Todorova ,
Kelly Mitchell ,
Charles Kenworthy,
Vincent Guerlavais,
D. Allen Annis,
Boris Bartholdy,
Britta Will
and other authors.
,
Daniela Ben Neriah,
Adrien Senecal ,
Lumie Benard ,
Victor Thiruthuvanathan ,
Tatyana Yatsenko ,
Swathi-Rao Narayanagari ,
Justin C. Wheat ,
Tihomira I. Todorova ,
Kelly Mitchell ,
Charles Kenworthy,
Vincent Guerlavais,
D. Allen Annis,
Boris Bartholdy,
Britta Will
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Dual inhibition of MDMX and MDM2 by an α-helical p53-stapled peptide (ALRN-6924) results in robust antitumor activity in acute myeloid leukemia.